PCSK9,HDL-

Maryam Darabi1, Marie Lhomme2, Maharajah Ponnaiah3

  • 1Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France; LPS-BioSciences (Current affiliation of Dr Darabi), Université de Paris-Saclay, Orsay, France.

PubMed
概括

功能增益的PCSK9变体会损害高密度脂蛋白 (HDL) 的功能并改变其组成,从而导致心血管风险. 这项研究揭示了对HDL的新见解.